Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lifecore Biomedical (LFCR)
NASDAQ:LFCR
Holding LFCR?
Track your performance easily
Earnings Data
Report Date
Apr 02, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.14Last Year’s EPS
0.4Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 02, 2018
|% Change Since: -9.16%
|Next Earnings Date:Jul 31, 2018
Earnings Call Sentiment|Positive
While Lifecore demonstrated notable growth in revenue, gross profit, and adjusted EBITDA, alongside successful financing and credit restructuring, the net loss and increased expenses present challenges that must be addressed. However, the strategic initiatives and leadership changes indicate a positive trajectory for future growth.Company Guidance
During the Lifecore Biomedical Q2 2025 earnings call, the company provided comprehensive guidance emphasizing several key metrics and strategic goals. Revenues for the second quarter rose to $32.6 million, marking an 8% increase from the previous year, largely driven by a $1.9 million rise in CDMO revenues and improved gross margins compared to Q1. Despite a net loss of $6.6 million, the company achieved an adjusted EBITDA of $6.5 million, reflecting a $1.1 million increase year-over-year. Lifecore aims for a 12% revenue CAGR and over 25% EBITDA margins in the coming years, supported by a strategic growth plan focusing on maximizing existing customer business, advancing development programs towards commercialization, and expanding business development efforts. Additionally, the company's balance sheet was strengthened with a $24.3 million PIPE offering and an amended revolving credit facility, positioning Lifecore for sustainable future growth.Revenue Growth
Revenues for the three months ended November 24, 2024, were $32.6 million, an increase of 8% compared to $30.2 million for the comparable prior year period.
Improved Gross Profit
Gross profit for the three months ended November 24, 2024, was $11.1 million compared to $10 million for the same period last year, reflecting a $1.1 million increase.
Adjusted EBITDA Increase
Adjusted EBITDA for the three months ended November 24, 2024, was $6.5 million, an increase of $1.1 million compared to $5.4 million in the prior year period.
Successful PIPE Financing
Successfully closed a $24.3 million PIPE offering, improving liquidity and supporting growth opportunities.
Revolving Credit Facility Amendment
Amended and extended the revolving credit facility with BMO, providing a 3-year extension and reduced interest rates.
New Business Development
Signed two new project agreements and expanded the business development pipeline by 2 programs.
Leadership and Operational Enhancements
Appointment of Thomas Guldager as Senior Vice President of Operations and Jackie Klecker as Executive Vice President of Quality and Development Services.
---
LFCR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
LFCR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jan 02, 2025 | $6.66 | $7.62 | +14.41% |
| Oct 04, 2024 | $4.70 | $5.38 | +14.47% |
| Aug 26, 2024 | $6.34 | $4.74 | -25.24% |
| Apr 02, 2024 | $5.79 | $5.52 | -4.66% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Lifecore Biomedical (LFCR) report earnings?
Lifecore Biomedical (LFCR) is schdueled to report earning on Apr 02, 2025, TBA Not Confirmed.
What is Lifecore Biomedical (LFCR) earnings time?
Lifecore Biomedical (LFCR) earnings time is at Apr 02, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LFCR EPS forecast?
LFCR EPS forecast for the fiscal quarter 2025 (Q3) is -0.14.
---